In August, our team went to the Keystone Conference on Long COVID in Santa Fe, and our Medical Director, Stuart Malcolm, spoke to @TheSickTimes about his experience being at the 3-day conference with 170 other experts: "Why I’m excited as an ME/Long COVID doctor is because

Dr. Jennifer Curtin, Co-Founder and Chief Medical Officer, shares the story behind building a platform shaped by both medical expertise and lived experience. After years of navigating her own undiagnosed conditions and seeing how many others faced the same struggle, she set out

Hedera’s architecture routes activity through its Hashgraph consensus, enabling high throughput and low-latency finality Core services—Consensus, Token, and Smart Contracts—support Payments, DeFi, NFTs, and Decentralized ID All governed by the Hedera Council

Please share 🙏@patientled @doctorasadkhan @exceedhergrasp1 @PlzSolveCFS @MEActNet @putrinolab @remissionbiome @IsabelRamirezRD @bhanlon15 @AngelaMSWinCA @loscharlos @tessfalor @jencurtinmd @BinitaKane @resiapretorius @LeoGallandMD

⁉️📣Calling those with #LongCOVID, #MECFS, or #POTS — As we expand access to targeted treatments, we want your input. Which of these medications would you most want to see us provide through RTHM Direct?

Have you tried Low Dose Naltrexone (LDN) for Long COVID, ME/CFS, or other chronic condition symptoms? According to our data from RTHM Direct, 52% of patients who were prescribed LDN reported symptom improvements, and 39% of those described the improvements as moderate to great

Dynex Capital ($DX) Co-CEO Smriti Popenoe joins @marketopolis_ to talk about building a company meant to last decades, not news cycles. She explains how Dynex treats dividends as risk infrastructure and how AI is giving retail investors new research power. 🎧 Listen now!

We’re live in 1 hour! Join us for a 90-minute conversation on how RTHM’s new HIPAA-compliant intelligence platform is reshaping care for complex and infection-associated chronic conditions. You’ll see how the platform connects your health history, symptoms, and research to

Join us for a 90-minute conversation on how RTHM’s new HIPAA-compliant intelligence platform is transforming care for complex and infection associated conditions. We’ll share the vision behind the platform, show how it works, and demonstrate how it connects your health history,

Join us for a 90-minute conversation exploring how RTHM’s new HIPAA-compliant intelligence platform is reshaping the future for complex and infection associated chronic conditions. Learn how RTHM’s free, easy-to-use intelligence platform connects your health history, symptoms,

What if you had a personal medical assistant in your pocket, one that could help you track your symptoms, labs, and history, and reveal what it all means? RTHM’s new intelligence platform uses AI to connect the dots across your health data and surface testing, diagnoses, and

With $GSOL now on @NYSE Arca, @Grayscale becomes one of the largest SOL ETP issuers, building on our leadership in Bitcoin & Ethereum ETPs. As one of the first pure-Solana products to enable staking, $GSOL brings $SOL exposure to investors through a familiar ETP wrapper.

From symptoms to solutions, RTHM’s new intelligence platform is here to take some of the weight off your shoulders. Share your story and bring your records together in one place so your full health picture is finally visible. RTHM’s new intelligence platform connects your

Living with Long COVID, ME/CFS, or EDS often means years of trial and error. Eliana shares how RTHM’s new intelligence platform connected her health history with the latest research to reveal treatment and testing options tailored to her case. Our platform is free,

Big announcement: RTHM’s intelligence platform has officially launched! For too long, people with complex chronic conditions have had to shoulder the burden of managing their medical journey on their own. RTHM’s new platform is changing that. RTHM’s new HIPAA-compliant

Have you tried ketotifen for Long COVID, ME/CFS, or MCAS-related symptoms? According to our data from patients using ketotifen through RTHM Direct, 43% of RTHM Direct patients *who were prescribed ketotifen* reported noticeable improvements in their symptoms, and 36% of those

Have you tried Low Dose Naltrexone (LDN) for Long COVID, ME/CFS, or other chronic condition symptoms? According to our data from RTHM Direct, 53% of patients who were prescribed LDN reported symptom improvements, and 39% of those described the improvements as moderate to

@patientled @doctorasadkhan @exceedhergrasp1 @PlzSolveCFS @MEActNet @putrinolab @remissionbiome @IsabelRamirezRD @bhanlon15 @AngelaMSWinCA @loscharlos @tessfalor @jencurtinmd @BinitaKane @resiapretorius @SnyderShot

⁉️📣 Calling those with #LongCOVID, #MECFS, or #POTS who have tried Low Dose Rapamycin – how did it affect your symptoms overall compared to your baseline? If you had improvements or worsening, let us know in the comments how long they have lasted. Please share 🙏

Low Dose Naltrexone (LDN) has helped many RTHM Direct patients manage the life-altering symptoms of ME/CFS, Long COVID, and related conditions. Before treatment, Corinne faced relentless brain fog, PEM, memory loss, and the inability to follow conversations without feeling